Reach us: 7304553123 / mktg@projectstoday.com
Help
1. Boolean Searches :

i. AND - Shows results where both terms on either side of the 'AND' operator are present. 'AND' must be in upper case. For example search term - delhi AND metro result - It will return records in which 'delhi' as well as 'metro' both are present.

ii. OR - Shows results where either term (or both terms) is present. 'OR' must be in upper case. For example search term - delhi OR metro result - It will return records in which either 'delhi' or 'metro' or both are present

2. Proximity Searches

A proximity search looks for terms that are within a specific distance from one another. For example, search term - 'delhi metro'~10 result - It will search for records where 'delhi' and 'metro' are found within 10 words of each other

3. Phrase searches

You can search phrases using double quotes. for e.g. 'delhi metro' result - It will return records where 'delhi metro' phrase is found.

Wockhardt inks pact with UK govt for COVID-19 vaccine

Tuesday, 04 Aug 2020
Share this on :
Wockhardt has entered into an agreement with the UK government to ‘fill finish’ COVID-19 vaccines.

This process, involving sourcing the bulk ingredient from another company and filling it into the injectable form of the vaccine, will be undertaken at CP Pharmaceuticals, a subsidiary of Wockhardt based in Wrexham, North Wales.

The company has reserved manufacturing capacity to allow for the supply of multiple vaccines to the UK government in its fight against the pandemic, including AZD1222, the vaccine co-invented by the University of Oxford and its spinout company, Vaccitech and licensed by AstraZeneca.

Wockhardt officials were in talks with the Indian government as well for similar arrangements at their Aurangabad plant, when a vaccine is available.

The UK plant will make 30 million doses and can scale up to 400 million doses in a couple of months, if required. Between the India and UK facilities, about a billion doses can be supplied.

The company has not started the ‘fill finish’ process ‘at risk’ and expects to do so once the other companies involved with this vaccine do the same.

New Password
Confirm Password